Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Immunology|June 1, 1994
Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA systemF Sellebjerg, J L Frederiksen, T Olsson, et al.
European Journal of Neurology|April 15, 2009
Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide studyA B Oturai, N Koch-Henriksen, T Petersen, et al.
Multiple Sclerosis and Related Disorders|December 12, 2025
Significance and stability of cerebrospinal fluid oligoclonal band patterns in multiple sclerosisV Swane, M Magyari, H Højsgaard Chow, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2005
CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosisF Sellebjerg, C Ross, N Koch-Henriksen, et al.
Acta Neurologica Scandinavica|May 22, 2007
Chemokine receptor CCR5 in interferon-treated multiple sclerosisF Sellebjerg, T B Kristiansen, P Wittenhagen, et al.
European Journal of Neurology|June 22, 2010
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?D Hesse, M Krakauer, H Lund, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosisE R Petersen, H B Søndergaard, A B Oturai, et al.
Multiple Sclerosis and Related Disorders|May 27, 2019
Illegal cannabis use is common among Danes with multiple sclerosisS Gustavsen, H B Søndergaard, S R Andresen, et al.
Multiple Sclerosis and Related Disorders|September 27, 2020
Biomarkers of inflammation and epithelial barrier function in multiple sclerosisA Olsson, S Gustavsen, I Chenoufi Hasselbalch, et al.
Pageof 10